Health issues for people over sixty commonly involve the heart and other vital organs. So do eye-related conditions such as cataracts and glaucoma, but dry eyes don't often come to mind. Or do they?
In fact, more than 70% of people in this age group are believed to suffer from meibomian gland disorder, the most common cause of dry eyes.
A new study led by researchers report that the loss of sex steroid hormones produced by the enzyme 3-hydroxyl-steroid dehydrogenase, or 3-HSD, causes the condition, but it can be treated with nicotinamide mononucleotide, or NMN, which is a non-steroid agent.
"Meibomian glands are found in the eyelids and have a role in producing the oil that coats the eyes. Without this oil, tears evaporate, " notes project leader.
Despite the high frequency of meibomian gland disorder, it does not appear to be life-threatening. Nevertheless, the chronic condition could lead to serious eye damage to the eyes if left untreated.
No curative therapy is currently available for meibomian gland disorder because the underlying molecular mechanisms are still unknown.
As we age, our hormone production decreases. The best-known examples are the sex hormones, such as testosterone and estrogen, which clearly correlate with age-associated incidence of meibomian gland disorder.
Classically, hormones are produced by endocrine organs and then enter the blood flow where they travel to regulate other parts of the body. However, using mutant mice, the study shows that instead of this endocrine system the meibomian gland depends on the more recently discovered intracrine system in which the hormone acts in the tissue where it is synthesized.
"Indeed, disturbed intracrine 3-HSD enzyme activity in mutant mice was found to result in atrophy of the gland, which further led to the disorder," the author concludes.
The research team's key interest in 3-HSD activity lies in its circadian rhythm, responsible for a number of oscillating physiological behaviors such as sleep, menstrual cycles, and hormone secretion. Further research on these circadian rhythms is expected to provide more clues on treating 3-HSD-related conditions.
The author adds, "We found that the enzymatic activity of 3-HSD peaked in mice just as they went to sleep. This observation suggests the timing of the drug administration is important.”
The oscillating activity of 3-HSD is attributed to the abundance in the gland of the 3-HSD cofactor nicotinamide adenine dinucleotide, or NAD, which is a coenzyme found in all cells and commonly sold as an over-the-counter supplement. It is also gaining attention as a compound in drug development for its ability to activate or inhibit hormone-producing enzymes including 3-HSD.
Confirming this point, the study shows that topically administering nicotinamide mononucleotide, or NMN, a precursor of NAD, elevates the amount of NAD needed to reboot 3-HSD activity. Adding NMN periodically to the meibomian gland of snoozing mice reduced atrophy of the meibomian gland, effectively alleviating dryness in the eyes.
Although steroids, such as testosterone, typically have unanticipated side effects, the author states, "Our study shows it is possible to avoid this problem not only with local treatment but also with a non-steroidal agent, such as NMN."
https://www.nature.com/articles/s43587-021-00167-8
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fintracrine-activity&filter=22
Combating age-associated dry eye disease
- 1,508 views
- Added
Edited
Latest News
Protein that helps COVID-19…
By newseditor
Posted 26 Jul
Spinal Muscular Atrophy (SM…
By newseditor
Posted 26 Jul
Link between bowel movement…
By newseditor
Posted 26 Jul
Inhibition of IL-11 signall…
By newseditor
Posted 25 Jul
Brain changes linked to obe…
By newseditor
Posted 25 Jul
Other Top Stories
Targeting fat-tissue hormone may lead to type 2 diabetes treatment
Read more
Liver signals to brain to control sugar intake
Read more
Protein Phosphorylation: A Major Switch Mechanism for Metabolic Reg…
Read more
The Genetics of Pediatric Obesity
Read more
The miRNA Interactome in Metabolic Homeostasis
Read more
Protocols
A systems biology approach…
By newseditor
Posted 24 Jul
quantms: a cloud-based pipe…
By newseditor
Posted 22 Jul
Emerging tools and best pra…
By newseditor
Posted 19 Jul
Directly selecting cell-typ…
By newseditor
Posted 17 Jul
PUFFFIN: an ultra-bright, c…
By newseditor
Posted 16 Jul
Publications
Hepatocyte-intrinsic SMN de…
By newseditor
Posted 26 Jul
Aberrant bowel movement fre…
By newseditor
Posted 26 Jul
A pseudoautosomal glycosyla…
By newseditor
Posted 26 Jul
Microglia protect against a…
By newseditor
Posted 26 Jul
Rigor and reproducibility i…
By newseditor
Posted 26 Jul
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar